189 related articles for article (PubMed ID: 35964500)
21. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
[TBL] [Abstract][Full Text] [Related]
22. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
23. Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents.
Zou X; Liu C; Li C; Fu R; Xu W; Bian H; Dong X; Zhao X; Xu Z; Zhang J; Shen Z
Eur J Med Chem; 2021 Dec; 225():113754. PubMed ID: 34399390
[TBL] [Abstract][Full Text] [Related]
24. [Synthesis and antitumor activity of podophyllotoxin derivatives].
Tian DL; Liang CP; Luo G; Chen H
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4874-4879. PubMed ID: 31872595
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of novel 4β-(1,3,4-oxadiazole-2-amino)-podophyllotoxin derivatives.
Ren J; Wu L; Xin WQ; Chen X; Hu K
Bioorg Med Chem Lett; 2012 Jul; 22(14):4778-82. PubMed ID: 22687745
[TBL] [Abstract][Full Text] [Related]
26. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
27. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents.
Xu XH; Guan XW; Feng SL; Ma YZ; Chen SW; Hui L
Bioorg Med Chem Lett; 2017 Jul; 27(13):2890-2894. PubMed ID: 28512026
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
[TBL] [Abstract][Full Text] [Related]
29. Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents.
Sun W; Sun F; Meng J; Cao X; Zhao S; Wang C; Li L; Jiang P
Bioorg Chem; 2022 Sep; 126():105906. PubMed ID: 35661529
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor activity of new tetrahydrocurcumin derivatives
Duan M; Mahal A; Mohammed B; Zhu Y; Tao H; Mai S; Al-Haideri M; Zhu Q
Nat Prod Res; 2022 Oct; 36(20):5268-5276. PubMed ID: 34030539
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents.
Nerella S; Kankala S; Paidakula S; Gavaji B
Bioorg Chem; 2020 Jan; 94():103384. PubMed ID: 31776036
[TBL] [Abstract][Full Text] [Related]
33. Diosgenin Derivatives as Potential Antitumor Agents: Synthesis, Cytotoxicity, and Mechanism of Action.
Yin H; Zhang MJ; An RF; Zhou J; Liu W; Morris-Natschke SL; Cheng YY; Lee KH; Huang XF
J Nat Prod; 2021 Mar; 84(3):616-629. PubMed ID: 33381964
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents.
Wang ZZ; Sun WX; Wang X; Zhang YH; Qiu HY; Qi JL; Pang YJ; Lu GH; Wang XM; Yu FG; Yang YH
Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Biological Evaluation of 4β-N-Acetylamino Substituted Podophyllotoxin Derivatives as Novel Anticancer Agents.
Wei J; Chen J; Ju P; Ma L; Chen L; Ma W; Zheng T; Yang G; Wang YX
Front Chem; 2019; 7():253. PubMed ID: 31106192
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).
Shaheen MA; El-Emam AA; El-Gohary NS
Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFR
Ding S; Dong X; Gao Z; Zheng X; Ji J; Zhang M; Liu F; Wu S; Li M; Song W; Shen J; Duan W; Liu J; Chen Y
Bioorg Chem; 2022 Jan; 118():105471. PubMed ID: 34798457
[TBL] [Abstract][Full Text] [Related]
38. Novel hybrids of podophyllotoxin and formononetin inhibit the growth, migration and invasion of lung cancer cells.
Yang C; Xie Q; Zeng X; Tao N; Xu Y; Chen Y; Wang J; Zhang L
Bioorg Chem; 2019 Apr; 85():445-454. PubMed ID: 30776555
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
40. Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents.
Hu C; Xu D; Du W; Qian S; Wang L; Lou J; He Q; Yang B; Hu Y
Mol Biosyst; 2010 Feb; 6(2):410-20. PubMed ID: 20094661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
